Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Aug;216(3):431-9.
doi: 10.1007/s00213-011-2235-2. Epub 2011 Mar 3.

Effects of the delta-opioid agonist SNC80 on the abuse liability of methadone in rhesus monkeys: a behavioral economic analysis

Affiliations

Effects of the delta-opioid agonist SNC80 on the abuse liability of methadone in rhesus monkeys: a behavioral economic analysis

Matthew L Banks et al. Psychopharmacology (Berl). 2011 Aug.

Abstract

Rationale: Delta-opioid agonists enhance the antinociceptive efficacy of methadone and other mu-opioid agonists. However, relatively little is known about the degree to which delta agonists might enhance the abuse-related effects of mu agonists.

Objective: This study used a behavioral economic approach to examine effects of the delta agonist SNC80 [(+)-4-[(αR)-α-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] on the reinforcing effects of methadone in a drug self-administration assay. Interactions between SNC80 and cocaine were also examined for comparison.

Methods: Rhesus monkeys (n = 4), surgically implanted with indwelling intravenous catheters, were tested in two phases. In phase 1, drug self-administration dose-effect curves for methadone (0.0032-0.1 mg/kg/injection (inj)) and cocaine (0.0032-0.32 mg/kg/inj) alone were determined under a fixed-ratio 10 (FR 10) schedule of reinforcement. In phase 2, FR values were increased every 3 days (FR 1-FR 1800) during availability of methadone alone (0.032 mg/kg/inj) and in combination with varying proportions of SNC80 (0.1:1, 0.3:1, and 0.9:1 SNC80/methadone) or of cocaine alone (0.032 mg/kg/inj) and in combination with varying proportions of SNC80 (0.33:1, 1:1, and 3:1 SNC80/cocaine). Demand curves related drug intake to FR price, and measures of reinforcement were derived.

Results: Methadone and cocaine alone each functioned as a reinforcer. SNC80 did not alter measures of reinforcement for either methadone or cocaine.

Conclusions: SNC80 at proportions previously shown to enhance methadone-induced antinociception did not enhance the abuse-related effects of methadone. These results support the proposition that delta agonists may selectively enhance mu agonist analgesic effects without enhancing mu agonist abuse liability.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Self-administration of intravenous methadone (0.0032–0.1 mg/ kg/inj) or cocaine (0.0032–0.32 mg/kg/inj) under a fixed-ratio 10 schedule of reinforcement in rhesus monkeys (n=4). Abscissa: unit dose of methadone or cocaine in milligrams/kilogram/injection (log scale). Ordinate: number of injections earned in the 120-min session. Downward triangle above S represents the mean±SEM number of injections delivered during saline substitution sessions that preceded test sessions. Upward triangle above C represents mean±SEM number of injections delivered during maintenance sessions of 0.032 mg/kg/inj cocaine availability that preceded test sessions. Filled symbols represent drug doses that maintained significantly greater self-administration than saline (p<0.05)
Fig. 2
Fig. 2
Effects of fixed-ratio manipulations on responding maintained by methadone (top panels) or cocaine (bottom panels) available alone or in mixtures with the delta-opioid agonist SNC80. Left panels (a and d) show the effects of varying the fixed ratio (log scale) on the numbers of injections per session. Center panels (b and e) show the same data but with rates of self-administration at each FR expressed as the percent self-administration rate at FR 1. Linear regression through these data was used to generate EFR50 values as a measure of reinforcement. Right panels (c and f) show the same data expressed as normalized demand curves. Non-linear regression through these curves using the exponential model of demand was used to generate 1/α values as a measure of reinforcement. All points represent the mean of four rhesus monkeys, and error bars show SEM. Filled symbols represent fixed ratios at which cocaine in some combination with SNC80 maintained significantly greater rates of self-administration than cocaine alone (p<0.05)
Fig. 3
Fig. 3
Correlation between EFR50 and 1/α metrics of reinforcement derived from curves shown in Fig. 2 b, c, e and f. Abscissa: log EFR50 values. Ordinate: log 1/α values. Each point represents the mean of four monkeys, and different symbols represent the different treatment conditions as shown in Fig. 2. Filled points represent methadone alone (filled circle) or in combinations with SNC80. Open points represent cocaine alone (open circle) or in combinations with SNC80. Linear regression was used to determine R2 and p values

References

    1. Adams JU, Tallarida RJ, Geller EB, Adler MW. Isobolo-graphic superadditivity between delta and mu opioid agonists in the rat depends on the ratio of compounds, the mu agonist and the analgesic assay used. J Pharmacol Exp Ther. 1993;266:1261–1267. - PubMed
    1. Banks ML, Gould RW, Czoty PW, Nader MA. Relationship between response rates and measures of reinforcing strength using a choice procedure in monkeys. Behav Pharmacol. 2008;19:365–369. - PMC - PubMed
    1. Banks ML, Folk JE, Rice KC, Negus SS. Selective enhancement of fentanyl-induced antinociception by the delta agonist SNC162 but not by ketamine in rhesus monkeys: further evidence supportive of delta agonists as candidate adjuncts to mu opioid analgesics. Pharmacol Biochem Behav. 2010;97:205–212. - PMC - PubMed
    1. Danielsson I, Gasior M, Stevenson GW, Folk JE, Rice KC, Negus SS. Electroencephalographic effects of the delta opioid agonist SNC80 in rhesus monkeys. Pharmacol Biochem Behav. 2006;85:428–434. - PMC - PubMed
    1. Dietis N, Guerrini R, Calo G, Salvadori S, Rowbotham DJ, Lambert DG. Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile. Br J Anaesth. 2009;103:38–49. - PubMed

Publication types

MeSH terms